06/08/2026
A single dose of psilocybin, the active compound found in 'magic mushrooms', has been found to produce significant improvements in depression compared to a placebo.
These are the promising results from the UK's first publicly-funded randomised controlled trial, led by researchers from the Institute of Psychiatry, Psychology & Neuroscience at King's College London, and funded by the National Institute for Health and Care Research and the NIHR Biomedical Resource Centre: Maudsley.
The study not only looked at the effectiveness of psilocybin as a treatment method, but also whether delivering care outside a hospital setting was possible and safe to do so.
Read more about this study:
The first publicly-funded randomised controlled trial in the UK has found that a single dose of psilocybin, the active compound found in 'magic mushrooms', produced significant improvements in depression compared to a placebo.